Whenever Indiana does legalize medical cannabis, Tyler Bryan will be ready.
Chris Ryan
Read More
Decoding Chris Baggott
Baggott’s early years were marked by the kind of pain, frustration, and failure that would wreck anyone not equipped with his tenacious belief that better things are around the corner.
Matthew Gonzales
Read More
Ersal Ozdemir’s 11th Hour
“We’re going to make one last run at it,” Ozdemir said of the Indy Eleven. “Something has to change.”
Adam Wren
Read More
What’s The Future Of Indy’s Shared Workspaces?
“You’re not just renting an office from us. You’re becoming part of a tight-knit community.”
Cory Schouten
Read More
What’s Going To Happen To Circle Centre?
Almost anyone who came of age in the ’70s and ’80s spent some leisure time strolling the spacious halls of an enclosed shopping mall.
Eric McAfee
Read More
Indy Can Become A Tech Hub Without The New Amazon Headquarters
But there are a few bugs in the program that gets the city there.
Cory Schouten
Read More
Handicapping Amazon's HQ2 Sweepstakes
Alexa, does Indy have a shot? Alexa?
Michael Rubino
Read More
Text Your Way To Your Next Job
The man behind the world’s first text-based interviewing platform
Joseph Ball
Read More
What's The Password?
“About 18 percent of venture-backed tech companies in the U.S. have at least one female founder on the team. Here, that number is only 8 percent.”
IM Editors
Read More
The Unblinding: Has Lilly Solved the Alzheimer’s Puzzle? — An Epilogue
The search continues.
Adam Wren
Read More
Why One Indy Tech-Industry Player Supports Refugee Resettlement
“It’s not just believing in it as a human and for humanity and for morality.”
Jussi Kent-Doolan
Read More
The Name of the Game: Forrest Lucas
What $122 million in naming rights buys you.
Evan West
Read More
On the Brand Wagon
Global brands like Airbnb and Under Armour are keeping an eye the progress of these three competing Indiana businesses.
Casey Patrick
Read More
“Mystery of Trump’s Orange Skin” Leads Writer to Indiana
Indianapolis was once proclaimed the “world’s tanning-bed capital.”
Evan West
Read More
The Unblinding: Has Lilly Solved The Alzheimer’s Puzzle?
Eli Lilly and Company has spent three decades and $3 billion in an Ahab-like quest to develop the world’s first effective drug to treat Alzheimer’s disease.